Sign In
Buy HALO
$69.82
+3.54 (+5.34%)
At Close: Jun 03, 2026
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs May 1.)
Arcturus Therapeutics Ltd (...
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Janssen-Cilag International NV (Janssen) received a Committee for Medicinal Products for Human Use (CHMP) Positive Opinion from the Euro
First Eagle Fund of America Comments on Halozyme Therapeutics
07:52pm, Wednesday, 29'th Apr 2020
First Eagle Fund of America Comments on Halozyme Therapeutics, Stocks: HALO, First Eagle Investment, release date:Apr 29, 2020
First Eagle Fund of America's 1st-Quarter Commentary
07:20pm, Wednesday, 29'th Apr 2020
First Eagle Fund of America's 1st-Quarter Commentary, Stocks: PRGO,HALO,BE,DVA,NVT,WYND,WH,MPC,MLM,POST, First Eagle Investment, release date:Apr 29, 2020
The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda
12:40pm, Wednesday, 29'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 28.) * AstraZeneca plc (NYSE: AZN) * Arcturus Therapeu
The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda
12:00am, Wednesday, 29'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs April 28.)
AstraZeneca plc (NYSE:...
Halozyme To Host First Quarter 2020 Financial Results Webcast and Conference Call
09:05pm, Tuesday, 28'th Apr 2020
Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the first quarter 2020 on Monday, May 11 at 4:30 p.m. ET / 1:30 p.m. PT. Dr. Helen Torley, president an
Analysts Estimate Halozyme Therapeutics (HALO) to Report a Decline in Earnings: What to Look Out for
04:33pm, Tuesday, 28'th Apr 2020
Halozyme Therapeutics (HALO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Halozyme Therapeutics (HALO) to Report a Decline in Earnings: What to Look Out for
04:33pm, Tuesday, 28'th Apr 2020
Halozyme Therapeutics (HALO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update
11:36am, Tuesday, 28'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs April 27)
AstraZeneca plc (NYSE: AZN...
Analysts Estimate Halozyme Therapeutics (HALO) to Report a Decline in Earnings: What to Look Out for
12:00am, Tuesday, 28'th Apr 2020Stocks That Hit 52-Week Highs On Monday
02:21pm, Monday, 27'th Apr 2020
During Monday's morning session, these companies made new 52-week highs.
Noteworthy Points:
The largest company by market cap to set a new 52-week high was Novo Nordisk...
Halozyme announces daratumumab NDA filed in Japan by Janssen HALO;JNJ
09:39am, Monday, 27'th Apr 2020
Halozyme announces daratumumab NDA filed in Japan by Janssen HALO JNJ
